- Korean companies are actively studying how to use mRNA technology not only to fight Covid-19 but to treat cancer.
- ST Pharm and Theragen Bio have signed a memorandum of understanding (MOU) to jointly study a “neo-antigen mRNA anticancer vaccine” and cooperation in CDMO (contract development manufacturing organization) business.
http://www.koreabiomed.com/news/articleView.html?idxno=11916